TIME, 10:00 a.m. local time ; , Tuesday, January 23, 2024 ; PLACE, Bradbury Thompson Alumni Cente ; , Washburn University Campus ; , 1701 S.W. Jewell Avenue ; , Topeka, Kansas ; ITEMS OF BUSINESS, (1) The election of two directors. ; , (2) An advisory (non-binding) vote on executive compensation as disclosed in the accompanying proxy statement. ; , (3) The ratification of the appointment of Deloitte & Touche LLP as Capitol Federal Financial, Inc.’s independent auditors for the fiscal year ending September 30, 2024 ; RECORD DATE, Holders of record of Capitol Federal Financial, Inc. common stock at the close of business on December 1, 2023 are entitled to vote at the annual meeting or any adjournment or postponement thereof. ; PROXY VOTING, It is important that your shares be represented and voted at the annual meeting. Regardless of whether you plan to attend the annual meeting, please read the accompanying proxy statement and then vote by the Internet, telephone or mail as promptly as possible.
Proxy Statement for Annual Meeting of Shareholders, 1 ; Frequently Asked Questions About the Annual Meeting, 1 ; Election of Directors (Proposal No. 1), 4 ; Information Regarding Nominees, 4 ; Director Skills & Demographics, 5 ; Emeritus Directors of the Board of Directors, 11 ; Ratification of the Appointment of KPMG LLP (Proposal No. 2), 11 ; Audit and Non-Audit Fees, 12 ; Advisory Vote on the Compensation of our Named Executive Officers (Proposal No. 3), 12 ; Security Ownership of Certain Beneficial Owners and Management, 13 ; Corporate Governance, 15 ; Meetings of the Board of Directors and its Committees, 15 ; Board Leadership Structure, 19 ; The Board’s Annual Self-Evaluation, 19 ; The Board’s Role in Risk Oversight, 20 ; Communications to the Board, 21 ; Code of Ethics and Environmental, Social & Governance, 21 ; Prohibition on Hedging or Pledging of Company Stock, 22 ; Director Independence, 22 ; Director Compensation, 22 ; Policy on Poison Pills, 24 ; Compensation Committee Interlocks and Insider Participation, 24 ; Management Information, 24 ; Compensation Discussion and Analysis, 26 ; Overview, 26 ; Business Strategy and Summary of 2023 Financial and Business Performance, 26 ; 2023 Executive Compensation Actions, 27 ; Say-on-Pay Vote, 28 ; Primary Responsibilities of our Compensation Committee, 28 ; Compensation Philosophy and Primary Objectives, 29 ; Compensation Process, 30 ; Elements of Compensation, 33 ; Compensation Actions in 2023 and 2024, 36 ; Clawback Policy, 38 ; Stock Ownership Guidelines, 39 ; Termination-Based Compensation, 39 ; Limitations on Tax Deductibility of Executive Compensation, 40 ; Perquisites and Other Benefits, 40
IRREVOCABLE FUNERAL EXPENSE TRUST ; WHOLE LIFE INSURANCE ; REFUSAL LETTERS
UNITED STATES · SECURITIES AND EXCHANGE COMMISSION · WASHINGTON, D.C. 20549 · FORM 8-K · CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) · OF THE SECURITIES EXCHANGE ACT OF 1934 · Date of Report: May 13, 2009 · (Date of earliest event reported) · INTERNATIONAL BUSINESS MACHINES CORPORATION · (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION ; Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ; o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ; o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Item 7.01 (Regulation FD Disclosure) ; Attachment I contains presentation materials for the morning session of IBM’s Investor Briefing on May 14, 2014. Attachment II (Non-GAAP Supplemental Materials) contains supplemental materials about non-GAAP financial measures in certain presentation materials for the morning and afternoon sessions of this event. IBM’s web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (...
Item 7.01 (Regulation FD Disclosure) ; Attachment I contains presentation materials for IBM’s Investor Briefing on February 26, 2015. Attachment II (Non-GAAP Supplementary Materials) contains supplementary materials about non-GAAP financial measures in certain presentation materials for this event. As part of the Investor Briefing, IBM’s senior executives are prepared to provide the following information, which is hereby filed: The company continues to expect to deliver $15.75 to $16.50 of o...
Item 7.01 (Regulation FD Disclosure) ; Attachment I contains presentation materials for the afternoon session of IBM’s Investor Briefing on May 14, 2014. See Attachment II (non-GAAP supplemental materials) in the Form 8-K dated May 14, 2014 filed earlier today, which contains supplemental materials about non-GAAP financial measures in certain presentation materials for the morning and afternoon sessions of this event. IBM’s web site (www.ibm.com) contains a significant amount of information ...
Key Takeaways Insurance companies set annuity rates and may determine a guaranteed rate for a... influence annuity rates. Today’s Best Guaranteed Annuity Rates by Term 1-Year: 5.55% 2...
New York · 001-00035 · 14-0689340 ; (State or other jurisdiction of incorporation) · (Commission File Number) · (IRS Employer Identification No.)